HARVITA: Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery

Sponsor
Medical University Innsbruck (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05931783
Collaborator
(none)
1,300
7
2
96
185.7
1.9

Study Details

Study Description

Brief Summary

Internal thoracic arteries can be harvested in skeletonized or pedicled technique. Latest research has posed a potential adverse effect of skeletonizing the internal thoracic arteries on graft patency rates and clinical outcome. Prospective, randomized, multi-centre trials are necessary to investigate the impact of harvesting technique of left internal thoracic artery (LITA) on graft patency rates and clinical outcome after coronary artery bypass grafting.

The primary aim of our study is to provide a prospective, randomized, multi-centre trial to evaluate the impact of harvesting technique of LITA on graft patency rates of LITA grafts at 2 years after surgery.

Secondary aim of our study is to provide a prospective, randomized, multi-centre trial to evaluate the impact of harvesting technique of LITA on short-term and mid-term clinical outcome parameters.

Condition or Disease Intervention/Treatment Phase
  • Procedure: skeletonized harvesting technique
  • Procedure: pedicled harvesting technique
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Randomized Comparison of HARVesting the Left Internal Thoracic Artery in a Skeletonized Versus Pedicled Technique: the HARVITA Trial
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2028
Anticipated Study Completion Date :
Aug 1, 2031

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: skeletonized harvesting technique

In skeletonized harvesting technique, only the left internal artery itself is harvested.

Procedure: skeletonized harvesting technique
In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in skeletonized technique. Thereby, only the artery itself is harvested.

Active Comparator: pedicled harvesting technique

In pedicled harvesting technique the left internal thoracic artery, it's accompanying veins and parts of the endothoracic fascia is harvested, creating a 1-2 cm broad pedicle.

Procedure: pedicled harvesting technique
In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in pedicled technique. Thereby, the artery will be harvested together with the accompanying veins, the endothoracic fascia and fatty tissue in order to create an 1-2 cm broad pedicle.

Outcome Measures

Primary Outcome Measures

  1. LITA graft occlusion/dysfunction in coronary CT angiography or invasive angiography [2 years (+/- 3 months) after surgery]

    The primary endpoint (LITA graft occlusion/dysfunction in coronary CT angiography or invasive angiography at 2 years (+/- 3 months) after surgery) will be compared between the two treatment groups (skeletonized or pedicled harvesting technique) using a 2-sided Chi-square test. Coronary CT angiography will be performed to assess the status of LITA grafts. LITA graft occlusion is defined as the absence of contrast detection in the lumen of the graft indicating a 100% occlusion of LITA graft. LITA graft dysfunction is defined as the suspicion of LITA graft dysfunction: either anatomical (anatomical stenosis ≥ 50% (for example due to plaques, stricture) at anastomotic site or in the course of the graft), functional (due to competitive flow) or unclear (diffuse small sized vessel without clear anatomical obstruction)

Secondary Outcome Measures

  1. composite outcome of all-cause death, myocardial infarction and repeated [1 year, 2 years and 5 years after surgery]

    The composite outcome of all-cause death, myocardial infarction and repeated revascularisation will be compared with Kaplan-Meier graphs together with log-rank testing.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of major coronary vessels including the left anterior descending artery (LAD) with or without a ≥50% stenosis of the left main artery).
Exclusion Criteria:
  • Age > 80 years

  • Planned CABG without LITA use

  • Preoperative mediastinal radiation therapy

  • Emergency operation

  • Minimal invasive coronary artery bypass surgery

  • Any concomitant cardiac or non-cardiac procedures

  • Previous cardiac surgery

  • Known contrast agent allergy

  • Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome

  • Chronic kidney disease (GFR <60ml/min/1.73m²)

  • Life expectancy of less than 5 years

  • Pregnancy

  • Hyperthyroidism

  • Iodine allergy

Intraoperative exclusion criteria:
  • Y/T graft off the LITA graft

  • LITA sequential grafting

  • LITA target vessel other than LAD

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Graz Graz Austria
2 Medical University of Innsbruck Innsbruck Austria
3 Medical University of Vienna Vienna Austria
4 University of Duisburg-Essen Essen Germany
5 University of Freiburg Freiburg Germany
6 University Hospital Gießen Gießen Germany
7 University of Jena Jena Germany

Sponsors and Collaborators

  • Medical University Innsbruck

Investigators

  • Principal Investigator: Hannes Abfalterer, Dr. med. univ., Medical University Innsbruck

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Medical University Innsbruck
ClinicalTrials.gov Identifier:
NCT05931783
Other Study ID Numbers:
  • 1135/2023
First Posted:
Jul 5, 2023
Last Update Posted:
Jul 5, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University Innsbruck
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 5, 2023